🔎 Trials Near Me

Home › Uveal Melanoma › Massachusetts › Boston

Uveal Melanoma clinical trials in Boston, MA

5 studies for Uveal Melanoma are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Study of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic Uveal Melanoma

RecruitingPhase 3
  • Dana Farber Cancer Institute, Boston
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT07804186

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

RecruitingPhase 1/2
  • Massachusetts General Hospital, Boston
Ages 18 and older · All sexes · Updated May 13, 2026 · NCT03686124

Neoadjuvant Darovasertib in Primary Uveal Melanoma

RecruitingPhase 3
  • Massachusetts General Hospital, Boston
Ages 18 and older · All sexes · Updated May 6, 2026 · NCT07015190

Immune Response to Percutaneous Hepatic Perfusion With Melphalan for Ocular Melanoma Metastatic to the Liver

Recruiting
  • Massachusetts General Hospital, Boston
Ages 18 and older · All sexes · Updated Mar 11, 2026 · NCT07364474

Uveal Melanoma trials in other cities

Other studies in Boston

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.